Seres Executives Buy Shares Amid Phase‑2 Pause, Boosting Investor Confidence
Seres insider buying signals confidence in its microbiome drug strategy, market access plans, and Phase 2 pipeline – a key indicator for investors.
4 minutes to read
Seres Therapeutics Inc